[Form 4] Equitable Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Equitable Holdings, Inc. (EQH) President and CEO and director Mark Pearson reported Form 4 transactions dated 11/18/2025. He exercised an employee stock option for 27,200 shares of common stock at an exercise price of $23.18 per share, then sold 35,965 shares at a weighted average price of $43.1051 and a further 3,735 shares at a weighted average price of $43.5268, with both sales executed in multiple trades.

Following these transactions, Pearson beneficially owns 680,275 and then 676,540 EQH shares directly, a figure that includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan. The filing notes that the option grant for 27,200 shares was made under the company’s 2019 Omnibus Incentive Plan and vested in three installments beginning on February 26, 2021. All reported sales and the option exercise were carried out under a Rule 10b5-1 trading plan adopted on May 16, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pearson Mark

(Last) (First) (Middle)

C/O EQUITABLE HOLDINGS, INC.

1345 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Equitable Holdings, Inc. [ EQH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		M		27,200(1)	A	$23.18	716,240(2)	D
Common Stock	11/18/2025		S		35,965(1)	D	$43.1051(3)	680,275(2)	D
Common Stock	11/18/2025		S		3,735(1)	D	$43.5268(4)	676,540(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$23.18	11/18/2025		M			27,200(1)	(5)	02/26/2030	Common Stock	27,200	$0	217,600	D

Explanation of Responses:

1. The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

2. Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

3. This transaction was executed in multiple trades at prices ranging from $42.4700 to $43.4699 The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

4. This transaction was executed in multiple trades at prices ranging from $43.4700 to $43.6200 The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

5. Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.

Remarks:

	/s/Ralph Petruzzo as attorney-in-fact for Mark Pearson	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EQH CEO Mark Pearson report on this Form 4?

Mark Pearson, President, CEO and director of Equitable Holdings, Inc. (EQH), reported exercising an employee stock option for 27,200 shares of common stock at $23.18 per share and selling 35,965 shares at a weighted average price of $43.1051 and 3,735 shares at a weighted average price of $43.5268 on 11/18/2025.

How many EQH shares does Mark Pearson beneficially own after the reported transactions?

After the reported transactions on 11/18/2025, Mark Pearson beneficially owns 676,540 shares of Equitable Holdings common stock directly. This amount includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

Were Mark Pearson’s EQH trades made under a Rule 10b5-1 trading plan?

Yes. The explanation section states that the sales and option exercise reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mark Pearson on May 16, 2025.

What stock option did Mark Pearson exercise in this EQH Form 4 filing?

Mark Pearson exercised an employee stock option to buy 27,200 shares of Equitable Holdings common stock at an exercise price of $23.18 per share. The option was granted under the issuer’s 2019 Omnibus Incentive Plan and vested in three installments beginning on February 26, 2021.

At what prices were Mark Pearson’s EQH share sales executed?

The filing reports two sale transactions on 11/18/2025: 35,965 shares sold at a weighted average price of $43.1051 per share, based on multiple trades in the range $42.4700 to $43.4699, and 3,735 shares sold at a weighted average price of $43.5268 per share, based on trades in the range $43.4700 to $43.6200.

What role does Mark Pearson hold at Equitable Holdings (EQH)?

Mark Pearson is reported as both a director and an officer of Equitable Holdings, Inc., serving as the company’s President and CEO.